(MedPage Today) — The use of neoadjuvant chemotherapy failed to improve disease-free survival (DFS) over upfront surgery in patients with locally advanced colon cancer, a phase III randomized trial showed.
Among 248 patients, the DFS rate at…
Source link : https://www.medpagetoday.com/hematologyoncology/coloncancer/120206
Author :
Publish date : 2026-03-06 20:06:00
Copyright for syndicated content belongs to the linked Source.
